Atarax Indication:

For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.

Atarax Mechanism Of Action:

Atarax's mechanism of action is not known. It has been shown in animal studies to have effects at multiple sites in the central nervous system, including the thalamus and limbic system. Atarax binds to GABAA receptors which interrupt neuronal communication in the reticular formation and spinal cord, causing sedation and altered perception of pain.

Atarax Drug Interactions:

Not Available

Atarax Food Interactions:

Not Available

Atarax Generic Name:


  • Meprobamat [German]
  • Meprobamatum [INN-Latin]
  • Meprobamato [Italian]
  • Meprobamato [INN-Spanish]
  • Meprobamic acid
  • DEA No. 2820
  • Procarbamide

Drug Type:

Small Molecule; Illicit; Approved


Well absorbed from the gastrointestinal tract.

Toxicity (Overdose):

Symptoms of overdose include coma, drowsiness, loss of muscle control, severely impaired breathing, shock, sluggishness, and unresponsiveness. Death has been reported with ingestion of as little as 12 g meprobamate and survival with as much as 40 g.

Protein Binding:

Not Available



Half Life:

Plasma half-life is about 10 hours.

Dosage Forms of Atarax:

Tablet Oral

Chemical IUPAC Name:

[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate

Organisms Affected:

Humans and other mammals

Atarax to general, pharmacology

General, pharmacology..